KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Humana (HUM) EBIT (2016 - 2025)

Humana (HUM) has disclosed EBIT for 16 consecutive years, with -$1.7 billion as the latest value for Q4 2025.

  • On a quarterly basis, EBIT changed N/A to -$1.7 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.7 billion, a N/A change, with the full-year FY2025 number at $2.7 billion, up 5.54% from a year prior.
  • EBIT was -$1.7 billion for Q4 2025 at Humana, down from $400.0 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $2.8 billion in Q3 2021 to a low of -$1.7 billion in Q4 2025.
  • A 4-year average of $864.3 million and a median of $1.2 billion in 2023 define the central range for EBIT.
  • Peak YoY movement for EBIT: crashed 139.79% in 2021, then soared 225.39% in 2022.
  • Humana's EBIT stood at $61.0 million in 2021, then soared by 103.28% to $124.0 million in 2022, then surged by 872.58% to $1.2 billion in 2023, then crashed by 237.4% to -$1.7 billion in 2025.
  • Per Business Quant, the three most recent readings for HUM's EBIT are -$1.7 billion (Q4 2025), $400.0 million (Q3 2025), and $898.0 million (Q2 2025).